Year Book of Pulmonary Diseases 2013

1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Asthma, Allergy, and Cystic Fibrosis - p. 7 5. Asthma - p. 8 6. Vitamin D Insufficiency and Severe Asthma Exacerbations in Puerto Rican Children - p. 9 7. Adherence rate to beclomethasone dipropionate and the level of asthma control - p. 10 8. Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids - p. 11 9. Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy - p. 12 10. 24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids - p. 13 11. A Systematic Review of Long-Acting β2-Agonists Versus Higher Doses of Inhaled Corticosteroids in Asthma - p. 14 12. Asthma controller delay and recurrence risk after an emergency department visit or hospitalization - p. 15 13. A Cost-Effectiveness Analysis of Inhaled Corticosteroid Delivery for Children with Asthma in the Emergency Department - p. 16 14. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma - p. 17 15. Status asthmaticus in the medical intensive care unit: A 30-year experience - p. 18 16. Association Between Evidence-Based Standardized Protocols in Emergency Departments With Childhood Asthma Outcomes: A Canadian Population-Based Study - p. 19 17. Cystic Fibrosis - p. 20 18. Personalized Medicine in Cystic Fibrosis: Dawning of a New Era - p. 21 19. Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation - p. 22 20. Role of Cystic Fibrosis Transmembrane Conductance Regulator in Patients With Chronic Sinopulmonary Disease - p. 23 21. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study - p. 24 22. Chronic Obstructive Pulmonary Disease - p. 25 23. Spirometric Predictors of Lung Function Decline and Mortality in Early Chronic Obstructive Pulmonary Disease - p. 26 24. Emphysema Scores Predict Death From COPD and Lung Cancer - p. 27 25. Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease - p. 28 26. Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD: A Prospective Cohort Study - p. 29 27. Discussing an uncertain future: end-of-life care conversations in chronic obstructive pulmonary disease. A systematic literature review and narrative synthesis - p. 30 28. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations - p. 31 29. Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled Trial - p. 32 30. Efficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease - p. 33 31. Significance of the microbiome in obstructive lung disease - p. 34 32. Comparison of Indacaterol With Tiotropium or Twice-Daily Long-Acting β-Agonists for Stable COPD: A Systematic Review - p. 35 33. Cognitive dysfunction in patients with chronic obstructive pulmonary disease – A systematic review - p. 36 34. Venous Thromboembolism in Patients with Chronic Obstructive Pulmonary Disease - p. 37 35. The Impact of COPD on Management and Outcomes of Patients Hospitalized With Acute Myocardial Infarction: A 10-Year Retrospective Observational Study - p. 38 36. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease - p. 39 37. Occupational Exposure to Dusts, Gases, and Fumes and Incidence of Chronic Obstructive Pulmonary Disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults - p. 40 38. Genome-Wide Association Studies Identify CHRNA5/3 and HTR4 in the Development of Airflow Obstruction - p. 41 39. Lung Cancer - p. 42 40. Epidemiology of Lung Cancer - p. 43 41. Cancer Statistics, 2012 - p. 44 42. Increasing Lung Cancer Death Rates Among Young Women in Southern and Midwestern States - p. 45 43. Lung Cancer Incidence and Mortality Among HIV-Infected and HIV-Uninfected Injection Drug Users - p. 46 44. Tobacco-Related Issues - p. 47 45. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis - p. 48 46. Short-term Pulmonary Effects of Using an Electronic Cigarette: Impact on Respiratory Flow Resistance, Impedance, and Exhaled Nitric Oxide - p. 49 47. An Unexpected Consequence of Electronic Cigarette Use - p. 50 48. A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation - p. 51 49. Lung Cancer Screening - p. 52 50. Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review - p. 53 51. When the Average Applies to No One: Personalized Decision Making About Potential Benefits of Lung Cancer Screening - p. 55 52. Lung Cancer Screening - p. 56 53. Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts - p. 57 54. Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation - p. 58 55. Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer: A Case–Control and Cohort Validation Study - p. 59 56. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT - p. 60 57. Diagnostic Evaluation - p. 61 58. Estimating Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer: A Cohort Study - p. 62 59. Lung cancer detection by canine scent: will there be a lab in the lab? - p. 63 60. Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer - p. 64 61. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon - p. 65 62. Lung Cancer Treatment - p. 66 63. Cancer Treatment and Survivorship Statistics, 2012 - p. 67 64. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer - p. 68 65. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer - p. 69 66. Patients’ Expectations about Effects of Chemotherapy for Advanced Cancer - p. 70 67. Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery - p. 71 68. Molecular Approach to Lung Cancer - p. 72 69. ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers - p. 73 70. Epigenetic Control of Gene Expression in the Lung - p. 74 71. Pleural, Interstitial Lung, and Pulmonary Vascular Disease - p. 75 72. Interstitial Lung Disease - p. 76 73. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study - p. 77 74. Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis - p. 78 75. Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy - p. 79 76. Pleural Disease - p. 80 77. Outcome of patients diagnosed with fibrinous pleuritis after medical thoracoscopy - p. 81 78. Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural Effusion: The TIME2 Randomized Controlled Trial - p. 82 79. Treatment of Malignant Pleural Effusion: A Cost-Effectiveness Analysis - p. 83 80. Pulmonary Vascular Disease - p. 84 81. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial - p. 85 82. Peripheral Extracorporeal Membrane Oxygenation: Comprehensive Therapy for High-Risk Massive Pulmonary Embolism - p. 86 83. Ordering CT pulmonary angiography to exclude pulmonary embolism: defense versus evidence in the emergency room - p. 87 84. Usefulness of Preemptive Anticoagulation in Patients With Suspected Pulmonary Embolism: A Decision Analysis - p. 88 85. Longitudinal Analysis Casts Doubt on the Presence of Genetic Anticipation in Heritable Pulmonary Arterial Hypertension - p. 89 86. Effects of Commercial Air Travel on Patients With Pulmonary Hypertension - p. 90 87. Safety and efficacy of exercise training in various forms of pulmonary hypertension - p. 91 88. The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension - p. 92 89. Atorvastatin in Pulmonary Arterial Hypertension (APATH) study - p. 93 90. Bloodstream Infections in Patients With Pulmonary Arterial Hypertension Treated With Intravenous Prostanoids: Insights From the REVEAL REGISTRY® - p. 94 91. Tadalafil for the Treatment of Pulmonary Arterial Hypertension: A Double-Blind 52-Week Uncontrolled Extension Study - p. 95 92. Effectiveness and Safety of Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Children - p. 96 93. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry - p. 97 94. An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry - p. 98 95. Community-Acquired Pneumonia - p. 99 96. Aging Population and Future Burden of Pneumococcal Pneumonia in the United States - p. 100 97. Pneumonia and pregnancy outcomes: a nationwide population-based study - p. 101 98. Association of Diagnostic Coding With Trends in Hospitalizations and Mortality of Patients With Pneumonia, 2003-2009 - p. 102 99. Influenza-Associated Pneumonia Among Hospitalized Patients With 2009 Pandemic Influenza A (H1N1) Virus—United States, 2009 - p. 103 100. The natural history of community-acquired pneumonia in COPD patients: A population database analysis - p. 104 101. Direct Comparison of Three Natriuretic Peptides for Prediction of Short- and Long-term Mortality in Patients With Community-Acquired Pneumonia - p. 105 102. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study - p. 106 103. Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis - p. 107 104. Predictive factors, microbiology and outcome of patients with parapneumonic effusion - p. 108 105. Prevalence of Methicillin-Resistant Staphylococcus aureus as an Etiology of Community-Acquired Pneumonia - p. 109 106. Predictors of In-Hospital vs Postdischarge Mortality in Pneumonia - p. 110 107. Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis - p. 111 108. Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia: A Randomized Trial - p. 112 109. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis - p. 113 110. Effect of a 3-Step Critical Pathway to Reduce Duration of Intravenous Antibiotic Therapy and Length of Stay in Community-Acquired Pneumonia: A Randomized Controlled Trial - p. 114 111. Lung Transplantation - p. 115 112. Clinical Ex Vivo Lung Perfusion–Pushing the Limits - p. 116 113. Excellent Clinical Outcomes From a National Donation-After-Determination-of-Cardiac-Death Lung Transplant Collaborative - p. 117 114. Outcome of critically ill lung transplant candidates on invasive respiratory support - p. 118 115. Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry - p. 119 116. Hypoalbuminemia and Early Mortality After Lung Transplantation: A Cohort Study - p. 120 117. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation - p. 121 118. Cavitatory lung disease in thoracic transplant recipients receiving sirolimus - p. 122 119. SaLUTaRy: Survey of lung transplant rejection - p. 123 120. A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation: A Sequential Cohort Analysis - p. 124 121. Exercise Training After Lung Transplantation Improves Participation in Daily Activity: A Randomized Controlled Trial - p. 125 122. Changes in Neurocognitive Functioning Following Lung Transplantation - p. 126 123. Risk of Post-Lung Transplant Renal Dysfunction in Adults With Cystic Fibrosis - p. 127 124. Survival and Extrapulmonary Course of Connective Tissue Disease After Lung Transplantation - p. 128 125. Sleep disorders - p. 129 126. Central Sleep Apnea and Heart Failure - p. 130 127. The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses - p. 131 128. Consequences of Sleep-Disordered Breathing - p. 132 129. Obstructive Sleep Apnea Affects Hospital Outcomes of Patients with non-ST-Elevation Acute Coronary Syndromes - p. 133 130. Obstructive sleep apnea and the risk of adverse pregnancy outcomes - p. 134 131. A 3-year longitudinal study of sleep disordered breathing in the elderly - p. 135 132. Cardiovascular Mortality in Obstructive Sleep Apnea in the Elderly: Role of Long-Term Continuous Positive Airway Pressure Treatment: A Prospective Observational Study - p. 136 133. Sleep-disordered Breathing and Cancer Mortality: Results from the Wisconsin Sleep Cohort Study - p. 137 134. CPAP Treatment and Benefits - p. 138 135. Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of Hypertension - p. 139 136. Obstructive Sleep Apnea: Effects of Continuous Positive Airway Pressure on Cardiac Remodeling as Assessed by Cardiac Biomarkers, Echocardiography and Cardiac MRI - p. 140 137. Control of OSA During Automatic Positive Airway Pressure Titration in a Clinical Case Series: Predictors and Accuracy of Device Download Data - p. 141 138. Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Events in Nonsleepy Patients With Obstructive Sleep Apnea: A Randomized Controlled Trial - p. 142 139. Continuous Positive Airway Pressure Treatment of Sleepy Patients with Milder Obstructive Sleep Apnea: Results of the CPAP Apnea Trial North American Program (CATNAP) Randomized Clinical Trial - p. 143 140. Non-CPAP Treatment of Sleep-Disordered Breathing - p. 144 141. Exercise Is Associated with a Reduced Incidence of Sleep-disordered Breathing - p. 145 142. Long-term follow-up of patients operated with Uvulopalatopharyngoplasty from 1985 to 1991 - p. 146 143. Acute Upper Airway Responses to Hypoglossal Nerve Stimulation during Sleep in Obstructive Sleep Apnea - p. 147 144. Surgical vs Conventional Therapy for Weight Loss Treatment of Obstructive Sleep Apnea: A Randomized Controlled Trial - p. 148 145. Non-Pulmonary Sleep - p. 149 146. Association of Insomnia and Short Sleep Duration With Atherosclerosis Risk in the Elderly - p. 150 147. Sleep Disturbances Among Soldiers with Combat-Related Traumatic Brain Injury - p. 151 148. Sleep Disruption Due to Hospital Noises: A Prospective Evaluation - p. 152 149. Self-Reported Sleep Characteristics and Mortality in Older Adults of Mexican Origin: Results From the Hispanic Established Population for the Epidemiologic Study of the Elderly - p. 153 150. Pediatric Sleep-Disordered Breathing - p. 154 151. Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome - p. 155 152. Critical Care Medicine - p. 156 153. Acute Respiratory Disorder Syndrome - p. 157 154. Venovenous Extracorporeal Membrane Oxygenation in Adults: Practical Aspects of Circuits, Cannulae, and Procedures - p. 158 155. Pharmacotherapy for Acute Respiratory Distress Syndrome - p. 160 156. The acute respiratory distress syndrome - p. 161 157. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material - p. 162 158. Trauma Issues - p. 163 159. A model for predicting primary blast lung injury - p. 164 160. Acute Respiratory Failure - p. 165 161. A comparison of immunomodulation therapies in mechanically ventilated patients with Guillain Barré syndrome - p. 166 162. Airway Management - p. 167 163. Complications and failure of airway management - p. 168 164. Ventilator-Associated Pneumonia - p. 169 165. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED - p. 170 166. Decreasing ventilator-associated pneumonia in the intensive care unit: A sustainable comprehensive quality improvement program - p. 171 167. Pulmonary Hypertension in the ICU - p. 172 168. Aggressive Surgical Treatment of Acute Pulmonary Embolism With Circulatory Collapse - p. 173 169. A Primary Pulmonary Artery Chondrosarcoma Manifesting as Acute Pulmonary Embolism - p. 174 170. World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation - p. 175 171. Imaging and Monitoring in the ICU - p. 176 172. Effect of Bedside Ultrasonography on the Certainty of Physician Clinical Decisionmaking for Septic Patients in the Emergency Department - p. 177 173. Accuracy of non-invasive measurement of haemoglobin concentration by pulse co-oximetry during steady-state and dynamic conditions in liver surgery - p. 178 174. Decrease in central venous catheter placement due to use of ultrasound guidance for peripheral intravenous catheters - p. 179 175. A 61-year-old man with cough and abnormal chest x-ray - p. 180 176. A National ICU Telemedicine Survey: Validation and Results - p. 181 177. A potentially hazardous complication during central venous catheterization: lost guidewire retained in the patient - p. 182 178. Miscellaneous - p. 183 179. Acquired Neuromuscular Weakness and Early Mobilization in the Intensive Care Unit - p. 184 180. Adverse events are common on the intensive care unit: results from a structured record review - p. 185 181. A Historical Perspective on Sepsis - p. 186 182. A 42-year-old woman with septic shock: an unexpected source - p. 187 183. A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis - p. 188 184. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors - p. 189 185. Recurrent Sepsis in a 69-Year-Old Woman - p. 190 186. Clinical characteristics and outcomes of obstetric patients admitted to the intensive care unit - p. 191